Acute risks include severe nausea, vomiting, dehydration, acute pancreatitis, and thyroid complications
Water, Butylene Glycol, Glutathione, Glycerin, Phenyl Trimethicone, Caprylic/Capric Triglyceride, 1,2-Hexanediol, Niacinamide, Polysorbate 60, Sodium Citrate, Cetearyl Olivate, Sorbitan Sesquioleate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Tromethamine, Sorbitan Olivate, Ammonium Acryloyldimethyltaurate/VP Copolymer, Xanthan Gum, Ethylhexylglycerin, Adenosine, Sorbitan Isostearate, Disodium EDTA, Tocopheryl Acetate, Lycopodium Clavatum Extract, Equisetum Arvense Extract, Cyclodextrin, Hydrogenated Lecithin, Arginine, Thioctic Acid, Polyglyceryl-10 Stearate, Panthenol, Malachite Extract, Tetrahydroxypropyl Ethylenediamine, Sodium Ascorbyl Phosphate, Biotin, Pyridoxine, Cyanocobalamin, Tocopherol, Thiamine HCl, Beta-carotene, Riboflavin
A final decision on whether to add these peptides to the 503A list will come later, following the formal rulemaking process
Neuropeptide and kinin antagonists
Sweetman A, Lack L, Catcheside PG, et al
These drugs can increase risk of serious infection and cancer (NIH 2013
